Athira Pharma raises $85 million in Series B round
The Seattle-based company is one of several that have raised venture capital and equity investment funding this week.
Roivant raises $200M in equity financing, valuing company at $7B
The company, founded by Vivek Ramaswamy, anticipates topline data from six Phase III trials next year. It raised $1.1 billion last year in a round led by SoftBank.
The Human Algorithm: What AI Can’t Replace in Pharma Engagement
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.
Orchard Therapeutics closes $150 million Series C round
The oversubscribed round comes just four months after acquisition of GSK's gene therapy portfolio.